These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6553321)

  • 1. Detecting ovarian cancer: a challenge for nursing assessment.
    Sargis NM
    Oncol Nurs Forum; 1983; 10(2):48-52. PubMed ID: 6553321
    [No Abstract]   [Full Text] [Related]  

  • 2. When your patient has ovarian cancer.
    Ivey CL
    RN; 1994 Nov; 57(11):26-31; quiz 32. PubMed ID: 7984877
    [No Abstract]   [Full Text] [Related]  

  • 3. [Laparoscopy and ovarian cancer].
    Tolino A; Di Serio C; Ronsini S; Chiacchio G; Borruto Caracciolo G
    Minerva Ginecol; 1988 Jun; 40(6):341-6. PubMed ID: 2974514
    [No Abstract]   [Full Text] [Related]  

  • 4. The accurate staging of ovarian cancer using 3T magnetic resonance imaging--a realistic option.
    Booth SJ; Turnbull LW; Poole DR; Richmond I
    BJOG; 2008 Jun; 115(7):894-901. PubMed ID: 18485169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer of epithelial origin--an update.
    Menczer J
    Isr J Med Sci; 1993 Aug; 29(8):477-83. PubMed ID: 8407278
    [No Abstract]   [Full Text] [Related]  

  • 6. Operative laparoscopy in the management of ovarian cancer.
    Amara DP; Nezhat C; Teng NN; Nezhat F; Nezhat C; Rosati M
    Surg Laparosc Endosc; 1996 Feb; 6(1):38-45. PubMed ID: 8808559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors.
    Begum FD; Høgdall E; Kjaer SK; Blaakaer J; Christensen IJ; Christensen L; Høgdall C
    Gynecol Oncol; 2009 May; 113(2):221-7. PubMed ID: 19261323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing ovarian cancer--a GP guide.
    Brinkmann D; Jacobs I
    Practitioner; 2001 Apr; 245(1621):276-9, 281-2, 286. PubMed ID: 11332002
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
    Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
    Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of soluble interleukin-2 receptors in patients with ovarian tumors.
    Gebauer G; Rieger M; Jäger W; Lang N
    Anticancer Res; 1999; 19(4A):2509-11. PubMed ID: 10470184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACR Appropriateness Criteria on staging and follow-up of ovarian cancer.
    Javitt MC
    J Am Coll Radiol; 2007 Sep; 4(9):586-9. PubMed ID: 17845961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in symptoms between patients with benign and malignant ovarian neoplasms.
    Attanucci CA; Ball HG; Zweizig SL; Chen AH
    Am J Obstet Gynecol; 2004 May; 190(5):1435-7. PubMed ID: 15167861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of early diagnosis in managing ovarian cancer.
    Dunleavey R
    Nurs Times; 2006 Oct 10-16; 102(41):28-9. PubMed ID: 17059048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An atypical presentation of ovarian cancer.
    Moustafa M; Beynon WB
    J Obstet Gynaecol; 2002 Jul; 22(4):455-6. PubMed ID: 12521490
    [No Abstract]   [Full Text] [Related]  

  • 15. Unusual presentation of stage I ovarian cancer associated with 20 litres of ascites.
    Cartwright B; Papachalarabous E; Tailor A
    J Obstet Gynaecol; 2008 Jan; 28(1):123-5. PubMed ID: 18259927
    [No Abstract]   [Full Text] [Related]  

  • 16. [Early detection and preoperative diagnosis of ovarian carcinoma].
    Kainz C
    Wien Med Wochenschr; 1996; 146(1-2):2-7. PubMed ID: 8835487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could high plasma bikunin predict a favorable outcome in ovarian cancer?
    McIntosh M
    Nat Clin Pract Oncol; 2005 Oct; 2(10):502-3. PubMed ID: 16205769
    [No Abstract]   [Full Text] [Related]  

  • 18. Ovarian cancer.
    Gajewski W; Legare RD
    Surg Oncol Clin N Am; 1998 Apr; 7(2):317-33. PubMed ID: 9537979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for expert histopathological assessment of ovarian cancer and borderline tumors.
    Sengupta PS; Shanks JH; Buckley CH; Ryder WD; Davies J; Reynolds K; Slade RJ; Kitchener HC; Jayson GC
    Br J Cancer; 2000 Feb; 82(4):760-2. PubMed ID: 10732741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
    Baron AT; Cora EM; Lafky JM; Boardman CH; Buenafe MC; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):103-13. PubMed ID: 12582019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.